Showing results (201-210 of 232) with videos related to

Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2022
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple MyelomaTomas Jelinek, Renata Bezdekova, David Zihala, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 14, 2014
Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene eraAlessandro Martino, Daniele Campa, Artur Jurczyszyn, et al.
Cancers|September 9, 2023
Outcome of Second Primary Malignancies Developing in Multiple Myeloma PatientsIrit Avivi, David H Vesole, Julio Davila-Valls, et al.
British Journal of Haematology|August 7, 2018
Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patientsAngelica Macauda, Eleonora Castelli, Gabriele Buda, et al.
Leukemia Research|December 3, 2015
Efficacy and safety of lenalidomide treatment in multiple myeloma (MM) patients--Report of the Polish Myeloma GroupL Usnarska-Zubkiewicz, J Dębski, A Butrym, et al.
Leukemia & Lymphoma|July 3, 2018
Secondary plasma cell leukemia: a multicenter retrospective study of 101 patientsArtur Jurczyszyn, Jorge J Castillo, Irit Avivi, et al.
American Journal of Hematology|April 7, 2022
Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factorsAlessandro Gozzetti, Andrea Guarnieri, Elena Zamagni, et al.
European Journal of Haematology|January 8, 2025
The Role of Lifestyle and Environmental Factors in the Pathogenesis of Multiple MyelomaAnna Suska, Agata Tyczyńska, Jan Maciej Zaucha, et al.
British Journal of Haematology|January 10, 2018
Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patientsArtur Jurczyszyn, Jakub Radocha, Julio Davila, et al.
Cancer|September 23, 2020
Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myelomaPashna N Munshi, David Vesole, Artur Jurczyszyn, et al.
Pageof 24